VAP Solutions
Ventilator-Associated Pneumonia (VAP) is a top clinical concern in healthcare today, associated with high incidence rates, mortality and costs.
- VAP may account for up to 60% of all deaths, due to Healthcare-Associated Infections (HAI).1
- Approximately 8 to 28% of critical care patients develop VAP.2
- Hospital-associated pneumonia patients have a mortality rate of 20%-33%.1
Airway Management
Kimberly-Clark has been a world leader in closed endotracheal systems and the only system of its kind featuring turbulent cleaning action. We offer a full portfolio of flexible and easy-to-use solutions to meet the needs of your patients.
More information
For more information regarding our products call our Customer Care line 1800 101 021, or email hccusto@kcc.com.
1 CDC. Guidelines for Preventing Healthcare-Associated Pneumonia, 2003. Recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR 2004; 53 (No. RR-3)
2 Chastre J, Fagon J. Ventilator-Associated Pneumonia. Crit Care Med 2002; 165: 867-903
